An in-depth look to BUKWANG PHARMACEUTICAL operating, investing, and financing activities

003000 free cash flow for Q3 24 is 7.48 B KRW. For 2023, 003000 free cash flow was -13.32 B KRW and operating cash flow was -10.5 B KRW.